BioCentury | Apr 28, 2014
Company News
Genetic Technologies, ImmunAid Ltd. other news
...2.3 million three-year options to purchase an ImmunAid share at A$1.35, and Genetic will pay ImmunAid...
...option fee of A$500,000 ($466,500). Last December, Jacobsen disposed 30 million Genetic shares. Following the ImmunAid...
...deal, Jacobsen's equity stake in the company will be 5.2% (see BioCentury, Jan. 6). The ImmunAid...
...option fee of A$500,000 ($466,500). Last December, Jacobsen disposed 30 million Genetic shares. Following the ImmunAid...
...deal, Jacobsen's equity stake in the company will be 5.2% (see BioCentury, Jan. 6). The ImmunAid...
